Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neurological Biomarkers

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1611776

This article is part of the Research TopicAI-Enhanced Biomarkers: Revolutionizing Early Detection and Precision Medicine in NeurodegenerationView all 3 articles

Machine Learning Identifies Neutrophil Extracellular Traps-Related Biomarkers for Acute Ischemic Stroke Diagnosis

Provisionally accepted
Haipeng  ZhangHaipeng Zhang1TI  WUTI WU2Xinghua  LiXinghua Li3Shuangqing  LiuShuangqing Liu1Yuanyuan  WangYuanyuan Wang1Yang  CaoYang Cao1*
  • 1Second Hospital of Tianjin Medical University, Tianjin, China
  • 2Tianjin Medical University General Hospital, Tianjin, China
  • 3Department of Laboratory Medicine, Fengyang College, Shanxi Medical University, Fenyang, China

The final, formatted version of the article will be published soon.

Purpose: This study aimed to investigate the diagnostic potential of neutrophil extracellular traps (NETs)-related genes in acute ischemic stroke (AIS) through comprehensive bioinformatics analysis. Methods: Two GEO datasets (GSE37587 and GSE16561) were integrated to identify differentially expressed genes (DEGs) between AIS patients and healthy controls. Gene Set Enrichment Analysis (GSEA) was performed to explore functional pathways, while single-sample GSEA (ssGSEA) was used to evaluate immune cell infiltration patterns. NETs-related DEGs (NDEGs) were identified by intersecting the DEGs with previously reported NETS-related genes. Functional enrichment of NDEGs was performed using Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Key genes were identified via machine learning algorithms, including Least absolute shrinkage and selection operator (LASSO) and random forest (RF). A diagnostic model was constructed based on the identified hub genes and validated using an independent dataset (GSE58294). Potential regulatory miRNAs and candidate therapeutic compounds were predicted using the TargetScan and DSigDB databases, respectively. Results: The discovery dataset included 73 AIS patients and 24 healthy controls, revealed 551 DEGs (225 upregulated, 326 downregulated). The analysis of ssGSEA revealed notable immune dysregulation in AIS patients, characterized by increased neutrophil infiltration and decreased level of Th17, Th1, and TFH cells. GSEA indicated that DEGs were enriched in neutrophil degranulation and innate immune system. NDEGs were significantly enriched in immune regulation and leukocyte apoptosis (GO) and NETs formation pathway (KEGG). Four hub genes—SRC, TLR8, FCAR, and HIF1A—were identified using LASSO and RF algorithms. A diagnostic model based on these genes yielded area under the curve (AUC) values of 0.880 in the training dataset and 0.936 in the validation dataset. Furthermore, three regulatory miRNAs (miR-146a-5p, miR-155-5p, and miR-21-5p) and 23 candidate therapeutic drugs were predicted. Conclusions: To our knowledge, this represents the first comprehensive investigation of NETs-related gene signatures in AIS patients compared with healthy controls. These findings deepen our understanding of immune cell infiltration and the underlying molecular mechanisms involved in stroke, offering novel insights that may enhance diagnostic accuracy and therapeutic strategies for AIS.

Keywords: ischemic stroke, neutrophil extracellular traps, Bioinformatics analysis, biomarker, machine learning

Received: 19 May 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Zhang, WU, Li, Liu, Wang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yang Cao, Second Hospital of Tianjin Medical University, Tianjin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.